Clinical Trials Logo

Delirium clinical trials

View clinical trials related to Delirium.

Filter by:

NCT ID: NCT06206473 Not yet recruiting - Delirium Clinical Trials

Cognitive Dysfunctions Associated With Delirium in Critically-ill ARDS Patients

DeSign
Start date: April 1, 2024
Phase: N/A
Study type: Interventional

Early cognitive assessment of critically-ill acute respiratory distress syndrome (ARDS) patients with delirium using a multidimensional electrophysiological evaluation battery (mEEG) to identify and characterize the neural correlates of cognitive dysfunctions associated with delirium (vigilance, attention, semantic and lexical processing, self-processing), and to develop a prognostic evaluation of neurocognitive and psychological disorders using an innovative non-behavioral approach.

NCT ID: NCT06195592 Active, not recruiting - Open-Heart Surgery Clinical Trials

Development of Delirium in Patients Undergoing Open-Heart Surgery

Start date: September 15, 2023
Phase:
Study type: Observational

Malnutrition is a prevalent issue among patients undergoing cardiac surgery. This can lead to delirium risk factors, including postoperative functional and cognitive impairment. Assessing the patient's nutritional status before open-heart surgery may decrease the incidence of delirium and the psychological and physiological problems associated with it. The objective of this study was to examine the relationship between nutritional status and the incidence of postoperative delirium in patients who have undergone open-heart surgery.

NCT ID: NCT06194474 Recruiting - Delirium Clinical Trials

Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients

Start date: September 5, 2022
Phase:
Study type: Observational

To evaluate the relationship between abnormal protein or metabolite expression levels in peripheral blood and postoperative delirium in elderly patients undergoing cardiac surgery.

NCT ID: NCT06192615 Not yet recruiting - Delirium Clinical Trials

Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)

MINDDS II
Start date: April 1, 2024
Phase: Phase 3
Study type: Interventional

This is a pragmatic phase III, randomized, blinded, double placebo-controlled, three-arm trial of elderly patients following cardiac surgery to assess the relationship between nighttime intravenous (IV) and sublingual dexmedetomidine on postoperative delirium and functional outcomes after surgery.

NCT ID: NCT06187792 Recruiting - ICU Delirium Clinical Trials

Constructing a Model of Pupillary Parameters in Predicting Delirium Among Critically Ill Patients in the Intensive Unit

Start date: October 4, 2023
Phase:
Study type: Observational

Delirium is commonly observed in critically ill patients in intensive care units (ICUs), imposing significant burdens on both patients and the healthcare system. Existing assessment tools have certain limitations. Studies have indicated a correlation between pupil parameters and neurological disorders including delirium. Automated Infrared Pupillometry, widely used in neurological disorders, is employed in this study to assess its accuracy and predictive power in evaluating delirium among critically ill patients. The aim is to investigate the accuracy and predictive capability of these parameters in assessing delirium, while identifying the optimal cut-off points. The research findings will contribute to enhancing early detection and prevention of delirium in ICU settings.

NCT ID: NCT06187389 Completed - Delirium Clinical Trials

Validation and Reliability of the Turkish 4AT Scale for Post-Anesthesia Awakening Delirium

Start date: March 1, 2023
Phase:
Study type: Observational

Background: Delirium is a common and serious condition in hospitalized patients that often leads to extended hospital stays and increased healthcare costs. Accurate and timely detection is essential for optimal patient outcome. Aims: This study aimed to adapt the internationally recognized 4 AT Delirium Diagnosis Scale to Turkish and to evaluate the validity and reliability of this tool for the Turkish patient population. Design: This study was structured and conducted at a state hospital from March to June 2023. Methods: The study included 188 participants, determined through a power analysis. The 4AT Delirium Test and additional assessment tools were used to ascertain the delirium status of the patients. Comprehensive statistical evaluations were conducted using SPSS 25.0, which included analyses, such as item difficulty indices, item discrimination, and chi-square tests. Ethical approval for this study was granted by the Non-Interventional Ethics Committee, ensured full compliance with the ethical standards set by the World Medical Association's Declaration of Helsinki. All participants provided informed consent before participation. Additionally, our results strictly adhered to the guidelines of the STROBE Checklist.

NCT ID: NCT06184945 Not yet recruiting - Pain Clinical Trials

Behavioral Economic & Staffing Strategies in the ICU

BEST-ICU
Start date: July 1, 2024
Phase: N/A
Study type: Interventional

The overarching goal of this study is to support the "real world" assessment of strategies used to foster adoption of several highly efficacious evidence-based practices in healthcare systems that provide care to critically ill adults with known health disparities. Investigators will specifically evaluate two discrete strategies grounded in behavioral economic and implementation science theory (i.e., real-time audit and feedback and registered nurse implementation facilitation) to increase adoption of the ABCDEF bundle in critically ill adults.

NCT ID: NCT06180876 Recruiting - Clinical trials for General Anesthetic Drug Adverse Reaction

Effect of Remimazolam on Postoperative Delirium

RED
Start date: May 25, 2022
Phase: N/A
Study type: Interventional

Remimazolam is a novel benzodiazepine with ultra-short onset and offset of its effect. It can be used for general anesthesia. However, classical benzodiazepine such as midazolam was reported to increase the risk of postoperative delirium. Thus, the investigators aim to investigate the effect of remimazolam general anesthesia on postoperative delirium in elderly patients.

NCT ID: NCT06178939 Not yet recruiting - Lung Neoplasms Clinical Trials

Effects of Cognitive Intervention Therapy on Postoperative Delirium

Start date: December 2023
Phase: N/A
Study type: Interventional

This study is a prospective, single-center, randomized controlled trial to compare whether applying cognitive intervention therapy before and after surgery in elderly patients aged 65 years or older undergoing non-cardiac surgery can reduce the incidence of postoperative delirium compared to conservative treatment.

NCT ID: NCT06178835 Completed - Clinical trials for Postoperative Delirium

EPO for Postop Delirium in Elderly Patients

Start date: September 12, 2017
Phase: Phase 4
Study type: Interventional

Postoperative delirium is a common complication after surgery. The underlying pathophysiology of this complication is unclear, however neuroinflammation and oxidative stress secondary to surgery had shown to be the cause of postoperative cognitive dysfunction and delirium. Erythropoietin represents non-erythropoietic effects of anti-inflammatory properties. The aims of this study were to determine the role of erythropoietin toward the development of postoperative delirium, in terms of changes in inflammatory reaction by affecting the innate immunity in elderly patients undergoing total joint arthroplasty surgery.